Quethera is a gene therapy company developing a novel treatment for glaucoma. The company targeted delivering gene products for neuroprotectants and their receptors directly to the eye. This could provide long term neuroprotection to the retinal ganglion cells (RGC) in the eye, preventing their death and visual field loss.
